Authors

• Zahra Jamal (ORCID: https://orcid.org/0000-0002-3817-6795)
• Anna Poggesi (ORCID: https://orcid.org/0000-0002-8694-0129)
• Laura L. Read (ORCID: https://orcid.org/0000-0002-1085-0995)
• James Kennedy (ORCID: https://orcid.org/0000-0002-9083-672X)
• Tim Clayton (ORCID: https://orcid.org/0000-0002-1266-3288)
• Rajesh Kharbanda (ORCID: https://orcid.org/0000-0002-5356-2395)
• David Hildick‐Smith (ORCID: https://orcid.org/0000-0002-1147-1436)
• Matthew Dodd (ORCID: https://orcid.org/0000-0002-6207-6604)
• Daniel J. Blackman (ORCID: https://orcid.org/0000-0001-9039-6130)
• Richard Evans (ORCID: https://orcid.org/0000-0003-4101-2131)

Institutions

• University of London (GB)
• University of Leeds (GB)
• University of Sussex (GB)
• Leeds Teaching Hospitals NHS Trust (GB)
• Oxford Health NHS Foundation Trust (GB)
• John Radcliffe Hospital (GB)
• National Institute for Health and Care Research (GB)
• University of Oxford (GB)
• London School of Hygiene & Tropical Medicine (GB)
• Oxford BioMedica (United Kingdom) (GB)
• University Hospitals Sussex NHS Foundation Trust (GB)
• University of Florence (IT)

Publication Details

Journal

Circulation

Published

2025-08-30

DOI

https://doi.org/10.1161/circulationaha.125.076761

Citations

3

Primary Topic

Cardiac Valve Diseases and Treatments

Type

article

Field-Weighted Citation Impact

4.16

Funders

• Boston Scientific Corporation
• British Heart Foundation